Press Releases July 24, 2026 08:00 AM

Amwell® to report second quarter 2026 operating results

Amwell to announce Q2 2026 financial results with subsequent earnings call and webcast

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
AMWL

Amwell, a leading SaaS-based healthcare technology platform provider, will release its second quarter 2026 operating results on August 4, 2026, after market close. The management team will present an earnings call and webcast to discuss performance and business updates. Amwell offers integrated technology-enabled care solutions serving large healthcare organizations, aiming to improve patient access and healthcare delivery.

Amwell® to report second quarter 2026 operating results
AMWL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Amwell specializes in a comprehensive SaaS platform enabling technology-enabled healthcare solutions.
  • The company will report Q2 2026 operating results and hold a live webcast to share insights.
  • Amwell serves large U.S. and global healthcare organizations, impacting the healthcare technology sector.

BOSTON, July 24, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2026 operating results after stock market trading hours on Tuesday, August 4.

Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update.

The live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days.

About Amwell  
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.

Investors:

Asher Dewhurst

[email protected]

Media:

[email protected]


Risks

  • Results could be influenced by market competition and adoption rates of telehealth services, affecting healthcare technology stocks.
  • Broader economic and regulatory changes in the healthcare industry could impact Amwell's growth and profitability.
  • Dependence on large healthcare clients exposes the company to contract renewals and partnership risks.

More from Press Releases

LGI Homes Expands in North Dallas with the Opening of Blue Ridge Crossing Jul 24, 2026 Liberty Global Reports Q2 2026 Results Jul 24, 2026 Gentex Reports Second Quarter 2026 Financial Results Jul 24, 2026 Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026 Jul 24, 2026 NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination) Jul 24, 2026